The AJMC® Ophthalmology compendium is a comprehensive resource for clinical news and expert insights for treatment of disorders of the eye.
April 21st 2025
The complete response letter (CRL) specifies that the current dosage duration of aflibercept is still safe but extending the duration is not approved.
Application of Recent Data in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Managed Care Insights and Strategies
1.5 Credits / Ophthalmology, Optometry
View More
Leveraging Novel Therapies to Transform Demodex Blepharitis Care
May 13, 2025 | 7:00 PM ET
View More
Patient-Centered Treatment Plans for Management of Neovascular (Wet) AMD and Diabetic Macular Edema: Insights on Recent Efficacy, Safety, and Real-World Data to Improve Adhere...
1.5 Credits / Ophthalmology/Optometry
View More
Leveraging Novel Therapies to Transform Demodex Blepharitis Care (6/11)
Jun 11, 2025 1:00 PM ET
View More
Integrating Multi-Cancer Early Detection Tests Into Clinical Practice: The Health Economics Perspective for Managed Care Professionals
1.5 Credits / Oncology
View More
The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes
1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry
View More
Lighting System Quality May Impact Color Discrimination in Patients With Glaucoma
June 4th 2021Patients with glaucoma who were tested under a quantum dot LED were able to better distinguish differences in color, indicating that the quality of light systems may have an impact on color discrimination.
Read More
Low Rate of Ocular Abnormalities Seen Among Newborns Exposed to SARS-CoV-2 In Utero
April 19th 2021A study of newborns exposed to SARS-CoV-2, the virus that causes COVID-19, during gestation found few instances of ocular abnormalities, with none detected in exposed infants who testing positive.
Read More
Study Finds Higher Rates of Hearing Loss Associated With Teprotumumab
March 23rd 2021Study findings presented at ENDO 2021, the Endocrine Society's annual meeting, show rates of hearing loss among 28 patients who took teprotumumab were higher than previously reported in phase 2 and 3 trials.
Read More
Comparing Treatment Outcomes in Eyes With Proliferative Diabetic Retinopathy and NVE, NVD
March 22nd 2021Disc neovascularization (NVD) was less frequent among patients with proliferative diabetic retinopathy but was associated with more resistance to currently available treatments compared with neovascularization elsewhere (NVE), according to post hoc analysis findings published in JAMA Ophthalmology.
Read More
Fear of COVID-19 Limits Patients’ Uptake of Ophthalmic Care
March 16th 2021Fear of exposure to COVID-19 is associated with patients missing ophthalmic care appointments, suggesting the potential importance of conveying practices’ infection-control measures, according to results of a non-validated survey.
Read More
Program Aims to Increase Genetic Testing for Inherited Retinal Degenerations
March 10th 2021Implementation of the free My Retina Tracker Genetic Testing Study program was associated with an increased proportion of patients with inherited retinal degeneration successfully obtaining genetic testing, according to analysis results published in JAMA Ophthalmology.
Read More
Scheimpflug Imaging Helps Predict Corneal Edema Resolution After DMEK
March 3rd 2021Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial keratoplasty (DMEK).
Read More
Study Supports Preschool-Based Vision Screening Programs to Increase Glasses Wear
March 1st 2021Research published in JAMA Ophthalmology supports the continued implementation of preschool-based vision screening programs, as nearly 3 of 4 preschool students consistently wore their glasses at school during the first year of use.
Read More
Survey: Thyroid Eye Disease Reduces Quality of Life Beyond Acute Phase
February 25th 2021A new survey conducted by Horizon Therapeutics highlighted the negative impacts thyroid eye disease have on patients’ quality of life, finding effects often continue beyond the acute disease phase and into a chronic phase.
Read More